Table 1 Comparison between ESBL and non-ESBL producing of E. coli or K. pneumoniae based on clinical variables
No | Variable | Bloodstream infection due to either E. coli or K. pneumoniae | p | |
|---|---|---|---|---|
ESBL-producing | Non ESBL-producing | |||
1 | Type of ward, n (%) | 0.32 | ||
General | 9 (25.0) | 12 (33.3) | ||
Malignancy | 7 (19.4) | 12 (33.3) | ||
Intensive | 12 (33.3) | 5 (13.9) | ||
Surgery | 3 (8.3) | 3 (8.3) | ||
Infection | 2 (5.6) | 3 (8.3) | ||
Other | 3 (8.3) | 1 (2.8) | ||
2 | Length of stay (day) | 0.85 | ||
Mean | 10.52 | 11.21 | ||
SD | 15.77 | 15.58 | ||
3 | Diagnosis, n (%) | 0.08 | ||
Sepsis | 23 (63.9) | 13 (36.1) | ||
SIRS | 5 (13.9) | 7 (19.4) | ||
Fever | 3 (8.3) | 3 (8.3) | ||
Other infection | 5 (13.9) | 13 (36.1) | ||
4 | Underlying disease/comorbid, n (%) | 0.09 | ||
Malignant disease | 10 (27.8) | 12 (33.3) | ||
Chronic disease | 6 (16.7) | 8 (22.2) | ||
Malignant and chronic diseases | 3 (8.3) | 5 (13.9) | ||
Chronic and endocrine disease | 0 (0) | 3 (8.3) | ||
Cholestasis | 3 (8.3) | 2 (5.6) | ||
Congenital disease | 6 (16.7) | 0 (0) | ||
Other | 7 (19.4) | 4 (11.1) | ||
5 | Survival in 14 days, n (%) | 0.59 | ||
Alive | 25 (69.4) | 28 (77.8) | ||
Died | 11 (30.6) | 8 (22.2) | ||
6 | Source of infection, n (%) | 0.60 | ||
Unknown | 14 (38.9) | 20 (55.6) | ||
Lung | 8 (22.2) | 4 (11.1) | ||
Gastrointestinal tract | 3 (8.3) | 4 (11.1) | ||
Urinary tract | 4 (11.1) | 3 (8.3) | ||
Skin | 3 (8.3) | 1 (2.8) | ||
Other | 4 (11.1) | 4 (11.1) | ||